Literature DB >> 17210993

DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma.

Joanne E Povey1, Fatemeh Darakhshan, Karen Robertson, Yvonne Bisset, Magda Mekky, Jonathan Rees, Val Doherty, Gina Kavanagh, Niall Anderson, Harry Campbell, Rona M MacKie, David W Melton.   

Abstract

The incidence of cutaneous melanoma is rising rapidly in a number of countries. The key environmental risk factor is exposure to the ultraviolet (UV) component in sunlight. The nucleotide excision repair (NER) pathway deals with the main forms of UV-induced DNA damage. We have investigated the hypothesis that polymorphisms in NER genes constitute genetic susceptibility factors for melanoma. However, not all melanomas arise on sun-exposed sites and so we investigated the hypothesis that genes involved in other pathways for the repair of oxidative DNA damage may also be involved in susceptibility to melanoma. Scotland, with its high incidence of melanoma and stable homogeneous population, was ideal for this case-control study, involving 596 Scottish melanoma patients and 441 population-based controls. Significant associations were found for the NER genes ERCC1 and XPF, with the strongest associations for melanoma cases aged 50 and under [ERCC1 odds ratio (OR) 1.59, P = 0.008; XPF OR 1.69, P = 0.003]. Although an XPD haplotype was associated with melanoma, it did not contain the variant 751 Gln allele, which has been associated with melanoma in some previous studies. No associations were found for the base excision repair and DNA damage response genes investigated. An association was also found for a polymorphism in the promoter of the vitamin D receptor gene, VDR (OR 1.88, P = 0.005). The products of the two NER genes, ERCC1 and XPF, where associations with melanoma were found, act together in a rate-limiting step in the repair pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210993     DOI: 10.1093/carcin/bgl257

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  32 in total

Review 1.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

2.  Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma.

Authors:  Chunying Li; Kexin Chen; Zhensheng Liu; Li-E Wang; Jeffrey E Gershenwald; Jeffrey E Lee; Victor G Prieto; Madeleine Duvic; Elizabeth A Grimm; Qingyi Wei
Journal:  J Invest Dermatol       Date:  2007-11-29       Impact factor: 8.551

3.  DNA repair variants, indoor tanning, and risk of melanoma.

Authors:  Salina M Torres; Li Luo; Jenna Lilyquist; Christine A Stidley; Kristina Flores; Kirsten A M White; Esther Erdei; Melissa Gonzales; Susan Paine; Rachel I Vogel; Deann Lazovich; Marianne Berwick
Journal:  Pigment Cell Melanoma Res       Date:  2013-06-03       Impact factor: 4.693

4.  XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck.

Authors:  Alec Vaezi; Xiaozhe Wang; Shama Buch; William Gooding; Lin Wang; Raja R Seethala; David T Weaver; Alan D D'Andrea; Athanassios Argiris; Marjorie Romkes; Laura J Niedernhofer; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2011-07-07       Impact factor: 12.531

5.  Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma.

Authors:  Cristiane Oliveira; José Augusto Rinck-Junior; Gustavo Jacob Lourenço; Aparecida Machado Moraes; Carmen Silvia Passos Lima
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-09       Impact factor: 4.553

6.  Current evidences on the XPG Asp1104His polymorphism and melanoma susceptibility: a meta-analysis based on case-control studies.

Authors:  Yuanzhi Xu; Guangjun Jiao; Li Wei; Ning Wang; Yajun Xue; Jin Lan; Yajie Wang; Chuan Liu; Meiqing Lou
Journal:  Mol Genet Genomics       Date:  2014-09-18       Impact factor: 3.291

7.  Association of Single Nucleotide Polymorphisms in XRCC1 (194) and XPD (751) with Age-related cataract.

Authors:  Tafheem Khosa; Sana Aslam; Saima Mustafa; Atif Akbar; Rehan Sadiq Shaikh; Furhan Iqbal
Journal:  Int Ophthalmol       Date:  2017-05-30       Impact factor: 2.031

8.  Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma.

Authors:  Yuhao Dong; Le Zhuang; Weiyuan Ma
Journal:  Tumour Biol       Date:  2013-02-03

9.  Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.

Authors:  Xiaohong Rose Yang; Ruth M Pfeiffer; William Wheeler; Meredith Yeager; Stephen Chanock; Margaret A Tucker; Alisa M Goldstein
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

10.  Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.

Authors:  Juliette A Randerson-Moor; John C Taylor; Faye Elliott; Yu-Mei Chang; Samantha Beswick; Kairen Kukalizch; Paul Affleck; Susan Leake; Sue Haynes; Birute Karpavicius; Jerry Marsden; Edwina Gerry; Linda Bale; Chandra Bertram; Helen Field; Julian H Barth; Isabel Dos Santos Silva; Anthony Swerdlow; Peter A Kanetsky; Jennifer H Barrett; D Timothy Bishop; Julia A Newton Bishop
Journal:  Eur J Cancer       Date:  2009-07-15       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.